Home
SUPN
SUPN News

Latest Supernus Pharmaceuticals Inc. (SUPN) News on July 27, 2024

Argus Research

3 days ago

SUPN: Raising target price to $24.00

Supernus Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024

GlobeNewswire

3 days ago

Supernus Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024

Argus Research

10 days ago

SUPN: Raising target price to $23.00

Argus Research

17 days ago

SUPN: What does Argus have to say about SUPN?

VanEck Semiconductor ETF Is Riskier Than You Think

Motley Fool

2 months ago

VanEck Semiconductor ETF Is Riskier Than You Think

A Wall Street Analyst Just Predicted Nvidia Would Hit a $10 Trillion Market Cap. Is That Actually Possible?

Motley Fool

2 months ago

A Wall Street Analyst Just Predicted Nvidia Would Hit a $10 Trillion Market Cap. Is That Actually Possible?

Norway wealth fund to vote against Musk's $56 billion Tesla pay package

Reuters

2 months ago

Norway wealth fund to vote against Musk's $56 billion Tesla pay package

Oberstdorfer Bergbahn Reports Full Year 2023 Earnings

Simply Wall St.

2 months ago

Oberstdorfer Bergbahn Reports Full Year 2023 Earnings

Director Gregory Pipkin Sells 82,238 Shares of Sable Offshore Corp (SOC)

GuruFocus.com

2 months ago

Director Gregory Pipkin Sells 82,238 Shares of Sable Offshore Corp (SOC)

Insider Sale: CFO Steven Tomsic Sells 30,000 Shares of Fox Corp (FOX)

GuruFocus.com

2 months ago

Insider Sale: CFO Steven Tomsic Sells 30,000 Shares of Fox Corp (FOX)

Insider Sale: Chief Legal Officer Jeff Lendino Sells Shares of Jamf Holding Corp (JAMF)

GuruFocus.com

2 months ago

Insider Sale: Chief Legal Officer Jeff Lendino Sells Shares of Jamf Holding Corp (JAMF)

Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)

GuruFocus.com

2 months ago

Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)

Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire

2 months ago

Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Do Options Traders Know Something About Supernus (SUPN) Stock We Don't?

Zacks

2 months ago

Do Options Traders Know Something About Supernus (SUPN) Stock We Don't?

MT Newswires

2 months ago

Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy

GlobeNewswire

2 months ago

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy

GuruFocus.com

3 months ago

Supernus Pharmaceuticals Reports Mixed Q1 2024 Results Amidst Strategic Shifts and Pipeline ...

Supernus Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.31 in 1Q 2023)

Simply Wall St.

3 months ago

Supernus Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.31 in 1Q 2023)

Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures

GlobeNewswire

3 months ago

Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript

GuruFocus.com

3 months ago

Supernus Pharmaceuticals Inc (SUPN) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Compared to Estimates, Supernus (SUPN) Q1 Earnings: A Look at Key Metrics

Zacks

3 months ago

Compared to Estimates, Supernus (SUPN) Q1 Earnings: A Look at Key Metrics

Supernus Announces First Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Supernus Announces First Quarter 2024 Financial Results

MT Newswires

3 months ago

Supernus, M8 Pharmaceuticals Sign Licensing Deal for ADHD Drug Qelbree in Latin America

M8 Pharmaceuticals, an Acino company, signs an exclusive licensing agreement with Supernus for Qelbree® (Viloxazine XR) in Latin America

PR Newswire

3 months ago

M8 Pharmaceuticals, an Acino company, signs an exclusive licensing agreement with Supernus for Qelbree® (Viloxazine XR) in Latin America

Ahead of Supernus (SUPN) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Zacks

3 months ago

Ahead of Supernus (SUPN) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story

GlobeNewswire

3 months ago

Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

GlobeNewswire

3 months ago

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

Argus Research

3 months ago

SUPN: What does Argus have to say about SUPN?

Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease

Benzinga

4 months ago

Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease

Supernus Provides Regulatory Update for SPN-830

GlobeNewswire

4 months ago

Supernus Provides Regulatory Update for SPN-830

Supernus to Participate in Two Upcoming Investor Conferences

GlobeNewswire

5 months ago

Supernus to Participate in Two Upcoming Investor Conferences

11 Best Small Cap Pharma Stocks to Invest In

Insider Monkey

5 months ago

11 Best Small Cap Pharma Stocks to Invest In

Supernus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

5 months ago

Supernus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference

GlobeNewswire

5 months ago

Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Supernus Pharmaceuticals Inc Earnings Call

Supernus (SUPN) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

5 months ago

Supernus (SUPN) Reports Q4 Earnings: What Key Metrics Have to Say

Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates

Zacks

5 months ago

Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates

Associated Press Finance

5 months ago

Supernus: Q4 Earnings Snapshot

Supernus Pharmaceuticals Inc (SUPN) Reports Robust Growth in Key Products for Full Year 2023

GuruFocus.com

5 months ago

Supernus Pharmaceuticals Inc (SUPN) Reports Robust Growth in Key Products for Full Year 2023

Supernus Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

5 months ago

Supernus Announces Fourth Quarter and Full Year 2023 Financial Results

Ahead of Supernus (SUPN) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Zacks

5 months ago

Ahead of Supernus (SUPN) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for

Zacks

5 months ago

Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024

GlobeNewswire

5 months ago

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024

Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent

GlobeNewswire

6 months ago

Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent

Solis Announces Amendment to Investor Awareness Services Contract With StocksDigital

Newsfile

6 months ago

Solis Announces Amendment to Investor Awareness Services Contract With StocksDigital

Investing in the stars: Space economy stocks to buy, avoid

Yahoo Finance Video

6 months ago

Investing in the stars: Space economy stocks to buy, avoid

Reuters

6 months ago

Goldman Sachs top executive Jim Esposito to depart - WSJ

GM looks for a road out of Tesla's shadow

Reuters

6 months ago

GM looks for a road out of Tesla's shadow

KRISPY KREME® Filling the World with Love for Valentine’s Day with New Dough-Notes Dozen

Business Wire

6 months ago

KRISPY KREME® Filling the World with Love for Valentine’s Day with New Dough-Notes Dozen

Goldman’s global banking and markets co-chief to leave bank

Banking Dive

6 months ago

Goldman’s global banking and markets co-chief to leave bank

This 10%-Plus Yielding Dividend Stock Continues to Push its Payout Higher

Motley Fool

6 months ago

This 10%-Plus Yielding Dividend Stock Continues to Push its Payout Higher

My Top 5 Growth Stocks to Buy in 2024

Motley Fool

6 months ago

My Top 5 Growth Stocks to Buy in 2024

Gentex (GNTX) Q4 Earnings and Revenues Top Estimates

Zacks

6 months ago

Gentex (GNTX) Q4 Earnings and Revenues Top Estimates

Weyerhaeuser adjusted profit chipped by tepid wood products sales

Reuters

6 months ago

Weyerhaeuser adjusted profit chipped by tepid wood products sales

Lowe's (LOW) Focuses on Pro Segment & Customer Engagement

Zacks

6 months ago

Lowe's (LOW) Focuses on Pro Segment & Customer Engagement

Investors Heavily Search BP p.l.c. (BP): Here is What You Need to Know

Zacks

6 months ago

Investors Heavily Search BP p.l.c. (BP): Here is What You Need to Know

Stride Inc (LRN) Reports Record Revenue and Profitability, Raises Full Year Guidance

GuruFocus.com

6 months ago

Stride Inc (LRN) Reports Record Revenue and Profitability, Raises Full Year Guidance

SAP's Q4 Earnings and Revenues Rise Y/Y on Cloud Strength

Zacks

6 months ago

SAP's Q4 Earnings and Revenues Rise Y/Y on Cloud Strength

Granite Construction (GVA) Upgraded to Strong Buy: Here's Why

Zacks

6 months ago

Granite Construction (GVA) Upgraded to Strong Buy: Here's Why

MakeMyTrip (MMYT) Tops Q3 Earnings and Revenue Estimates

Zacks

6 months ago

MakeMyTrip (MMYT) Tops Q3 Earnings and Revenue Estimates

Kratos (KTOS) Wins $50M Deal for CUAS & Air Defense Systems

Zacks

6 months ago

Kratos (KTOS) Wins $50M Deal for CUAS & Air Defense Systems

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Simply Wall St.

6 months ago

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Should You Investigate Spectrum Brands Holdings, Inc. (NYSE:SPB) At US$78.99?

Simply Wall St.

7 months ago

Should You Investigate Spectrum Brands Holdings, Inc. (NYSE:SPB) At US$78.99?

NMI Holdings (NASDAQ:NMIH) Ticks All The Boxes When It Comes To Earnings Growth

Simply Wall St.

7 months ago

NMI Holdings (NASDAQ:NMIH) Ticks All The Boxes When It Comes To Earnings Growth

Business Wire

7 months ago

Cohu to Participate at 26th Annual Needham Virtual Growth Conference

ABM Industries Incorporated (NYSE:ABM) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Simply Wall St.

7 months ago

ABM Industries Incorporated (NYSE:ABM) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Zacks Industry Outlook Highlights Norsk Hydro ASA, AB SKF, ESAB, Century Aluminum and TriMas

Zacks

7 months ago

Zacks Industry Outlook Highlights Norsk Hydro ASA, AB SKF, ESAB, Century Aluminum and TriMas

12 Best Prison and Law Enforcement Stocks to Buy Now

Insider Monkey

7 months ago

12 Best Prison and Law Enforcement Stocks to Buy Now

Knight Therapeutics Enters into Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree® (viloxazine) in Canada

GlobeNewswire

7 months ago

Knight Therapeutics Enters into Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree® (viloxazine) in Canada

Institutional investors control 65% of Blackstone Mortgage Trust, Inc. (NYSE:BXMT) and were rewarded last week after stock increased 11%

Simply Wall St.

7 months ago

Institutional investors control 65% of Blackstone Mortgage Trust, Inc. (NYSE:BXMT) and were rewarded last week after stock increased 11%

Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential

InvestorPlace

7 months ago

Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential

Is FTAI Aviation (FTAI) a Well Positioned Company in the Industry?

Insider Monkey

7 months ago

Is FTAI Aviation (FTAI) a Well Positioned Company in the Industry?

If EPS Growth Is Important To You, Middleby (NASDAQ:MIDD) Presents An Opportunity

Simply Wall St.

7 months ago

If EPS Growth Is Important To You, Middleby (NASDAQ:MIDD) Presents An Opportunity

Atlantic Union Bankshares Corporation Names Three New Board Members

Business Wire

8 months ago

Atlantic Union Bankshares Corporation Names Three New Board Members

Supernus Pharmaceuticals (NASDAQ:SUPN) shareholders have earned a 8.7% CAGR over the last three years

Simply Wall St.

8 months ago

Supernus Pharmaceuticals (NASDAQ:SUPN) shareholders have earned a 8.7% CAGR over the last three years

Baytex Announces Sale of Viking Assets at Forgan and Plato

Newsfile

8 months ago

Baytex Announces Sale of Viking Assets at Forgan and Plato

Insider Sell Alert: Director Frederick Hudson Sells 9,093 Shares of Supernus Pharmaceuticals ...

GuruFocus.com

8 months ago

Insider Sell Alert: Director Frederick Hudson Sells 9,093 Shares of Supernus Pharmaceuticals ...

20 Most Valuable Brazilian Companies Heading into 2024

Insider Monkey

8 months ago

20 Most Valuable Brazilian Companies Heading into 2024

Reynolds Consumer Products (NASDAQ:REYN) Is Due To Pay A Dividend Of $0.23

Simply Wall St.

8 months ago

Reynolds Consumer Products (NASDAQ:REYN) Is Due To Pay A Dividend Of $0.23

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Supernus Pharmaceuticals Inc Earnings Call

Supernus (SUPN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

9 months ago

Supernus (SUPN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Share on Social Networks: